Moussa; Adel M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Moussa; Adel M..The latest application filed is for "d-amino acid compounds for liver disease".

Company Profile

7.29.41

Moussa; Adel M. - Burlington MA
Moussa; Adel M. - Boston MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
2',4'-bridged nucleosides for HCV infection Grant 10,723,754 - Mayes , et al.	2020-07-28
D-amino acid compounds for liver disease Grant 10,717,758 - Mayes , et al.	2020-07-21
4'-or nucleosides for the treatment of HCV Grant 10,683,321 - Dukhan , et al.	2020-06-16
2'-chloro nucleoside analogs for HCV infection Grant 10,513,534 - Gosselin , et al. Dec	2019-12-24
Process for making nucleoside phosphoramidate compounds Grant 10,251,903 - Simmons , et al.	2019-04-09
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease Grant 10,238,680 - Mayes , et al.	2019-03-26
Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of HCV Grant 10,231,986 - Dukhan , et al.	2019-03-19
D-amino Acid Compounds For Liver Disease App 20180258130 - MAYES; Benjamin Alexander ; et al.	2018-09-13
4'-or Nucleosides For The Treatment Of Hcv App 20180162898 - Dukhan; David ; et al.	2018-06-14
Process for Making Nucleoside Phosphoramidate Compounds App 20170246198 - SIMMONS; Bryon L. ; et al.	2017-08-31
Pharmaceutical Compositions Comprising A 5,5-fused Heteroarylene Flaviviridae Inhibitor And Their Use For Treating Or Preventing Flaviviridae Infection App 20170135990 - Moussa; Adel M. ; et al.	2017-05-18
Solid Prodrug Forms Of 2'-chloro-2'-methyl Uridine For Hcv App 20170066795 - Sulliva-Bolyai; John Zoltan ; et al.	2017-03-09
Solid Forms Of A Flaviviridae Virus Inhibitor Compound And Salts Thereof App 20170066779 - Moussa; Adel M. ; et al.	2017-03-09
Cyclopentane And Cyclopentene Nucleoside Analogs For The Treatment Of Hcv App 20160280729 - Moussa; Adel M. ; et al.	2016-09-29
D-alanine Phosphoramide Pronucleotides Of 2'-methyl 2'-fluro Guanosine Nucleoside Compounds For The Treatment Of Hcv App 20160271162 - Moussa; Adel M. ; et al.	2016-09-22
Thiophosphate nucleosides for the treatment of HCV Grant 9,339,541 - Dousson , et al. May 17, 2	2016-05-17
Amino Acid Phosphoramidate Pronucleotides Of 2'-cyano, Azido And Amino Nucleosides For The Treatment Of Hcv App 20160113956 - DUKHAN; David ; et al.	2016-04-28
3'-deoxy nucleosides for the treatment of HCV Grant 9,309,275 - Stewart , et al. April 12, 2	2016-04-12
D-amino Acid Phosphoramidate Pronucleotides Of Halogeno Pyrimidine Compounds For Liver Disease App 20160082030 - Mayes; Benjamin Alexander ; et al.	2016-03-24
2'-chloro Nucleoside Analogs For Hcv Infection App 20160083413 - Gosselin; Gilles ; et al.	2016-03-24
D-amino Acid Compounds For Liver Disease App 20160002281 - MAYES; Benjamin Alexander ; et al.	2016-01-07
4'-fluoro nucleosides for the treatment of HCV Grant 9,211,300 - Mayes , et al. December 15, 2	2015-12-15
Esters and malonates of SATE prodrugs Grant 9,192,621 - Mayes , et al. November 24, 2	2015-11-24
2',4'-fluoro nucleosides for the treatment of HCV Grant 9,187,515 - Mayes , et al. November 17, 2	2015-11-17
3',5'-cyclic phosphoramidate prodrugs for HCV infection Grant 9,109,001 - Parsy , et al. August 18, 2	2015-08-18
D-amino Acid Phosphoramidate Pronucleotides Of Halogeno Pyrimidine Compounds For Liver Disease App 20150037282 - MAYES; Benjamin Alexander ; et al.	2015-02-05
2',4'-fluoro Nucleosides For The Treatment Of Hcv App 20140294769 - MAYES; Benjamin Alexander ; et al.	2014-10-02
3'-deoxy Nucleosides For The Treatment Of Hcv App 20140248241 - STEWART; Alistair James ; et al.	2014-09-04
Thiophosphate Nucleosides For The Treatment Of Hcv App 20140248242 - DOUSSON; Cyril B. ; et al.	2014-09-04
4'-fluoro Nuclosides For The Treatment Of Hcv App 20140178338 - MAYES; Benjamin Alexander ; et al.	2014-06-26
D-Alanine Ester of Sp-Nucleoside Analog App 20140140952 - MOUSSA; Adel M. ; et al.	2014-05-22
D-Alanine Ester of Rp-Nucleoside Analog App 20140140951 - MOUSSA; Adel M. ; et al.	2014-05-22
2',4'-bridged Nucleosides For Hcv Infection App 20140112887 - MAYES; Benjamin Alexander ; et al.	2014-04-24
Dinucleotide Compounds For Hcv Infection App 20140112886 - MOUSSA; Adel M. ; et al.	2014-04-24
2'-chloro Nucleoside Analogs For Hcv Infection App 20140099283 - GOSSELIN; Gilles ; et al.	2014-04-10
Esters and Malonates of SATE Prodrugs App 20140086873 - Mayes; Benjamin Alexander ; et al.	2014-03-27
3',5'-cyclic Phosphoramidate Prodrugs For Hcv Infection App 20130315866 - PARSY; Christophe Claude ; et al.	2013-11-28
D-amino Acid Compounds For Liver Disease App 20130315868 - MAYES; Benjamin Alexander ; et al.	2013-11-28
Pharmaceutical Compositions of 2'-C-Methyl-Guanosine, 5'-[2[(3-Hydroxy-2,2-Dimethyl-1-Oxopropyl)Thio]Ethyl N-(Phenylmethyl)Phosphoramidate] App 20130217644 - MAYES; Benjamin Alexander ; et al.	2013-08-22
Enantiomerically pure phosphoindoles as HIV inhibitors Grant 8,486,991 - Storer , et al. July 16, 2	2013-07-16
Solid forms of an anti-HIV phosphoindole compound Grant 8,470,870 - Moussa , et al. June 25, 2	2013-06-25
Enantiomerically Pure Phosphoindoles As Hiv Inhibitors App 20110257129 - Storer; Richard ; et al.	2011-10-20
Enantiomerically pure phosphoindoles as HIV inhibitors Grant 7,960,428 - Storer , et al. June 14, 2	2011-06-14
Solid Forms Of An Anti-hiv Phosphoindole Compound App 20110039803 - Moussa; Adel M. ; et al.	2011-02-17
Process for the production of 2-C-methyl-D-ribonolactone Grant 7,598,373 - Storer , et al. October 6, 2	2009-10-06
Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease Grant 7,531,573 - Brugnara , et al. May 12, 2	2009-05-12
Enantiomerically pure phosphoindoles as HIV inhibitors App 20080213217 - Storer; Richard ; et al.	2008-09-04
Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation Grant 7,342,038 - Brugnara , et al. March 11, 2	2008-03-11
Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation Grant 6,992,079 - Brugnara , et al. January 31, 2	2006-01-31
Process for the production of 2'-branched nucleosides App 20050020825 - Storer, Richard ; et al.	2005-01-27
Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation App 20040242563 - Brugnara, Carlo ; et al.	2004-12-02
Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation Grant 6,800,658 - Brugnara , et al. October 5, 2	2004-10-05
Process for the production of 3'-nucleoside prodrugs App 20040181051 - Storer, Richard ; et al.	2004-09-16
Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease App 20040127464 - Brugnara, Carlo ; et al.	2004-07-01
Methods of separating FTC isomers and derivatives thereof Grant 6,752,929 - Zahr , et al. June 22, 2	2004-06-22
Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation App 20040002486 - Brugnara, Carlo ; et al.	2004-01-01
Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation App 20030191111 - Brugnara, Carlo ; et al.	2003-10-09
Methods For The Treatment Or Prevention Of Inflammatory Diseases Characterized By Abnormal Cell Proliferation App 20030134842 - BRUGNARA, CARLO ; et al.	2003-07-17
Substitute 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation Grant 6,534,497 - Brugnara , et al. March 18, 2	2003-03-18
Synthesis of nitroalcohol diastereomers App 20030040644 - Gabriel, Richard L. ; et al.	2003-02-27
Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation App 20020198188 - Brugnara, Carlo ; et al.	2002-12-26
Synthesis of nitroalcohol diastereomers Grant 6,462,221 - Gabriel , et al. October 8, 2	2002-10-08
Methods for the treatment or prevention of inflammatory diseases characterized by abnormal cell proliferation App 20020128256 - Brugnara, Carlo ; et al.	2002-09-12
Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease App 20020119953 - Brugnara, Carlo ; et al.	2002-08-29
Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease Grant 6,331,564 - Brugnara , et al. December 18, 2	2001-12-18
Synthesis of 11-aryl-5,6,-dihydro-11H-dibenz [b,e] azepines App 20010007030 - Moussa, Adel M. ; et al.	2001-07-05
Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation Grant 6,028,103 - Brugnara , et al. February 22, 2	2000-02-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.